Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

NCT03675282 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
REM Sleep Behavior Disorder
Healthy

Interventions

DRUG: (11C)PE2I
DRUG: Ioflupane

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]